TG THERAPEUTICS, INC. Form D Notices of Exempt Offering of Securities
Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.
- 2012-03-26: Federal exemption Rule 506; Types of securities offered Equity; OptionToAcquire; SecurityToBeAcquired; Date of first sale 2011-12-30; Total offering amount $25,000,000.
- 2012-02-29: Federal exemption Rule 506; Types of securities offered Equity; OptionToAcquire; SecurityToBeAcquired; Date of first sale 2011-12-30; Total offering amount $25,000,000.
- 2012-02-22: Federal exemption Rule 506; Types of securities offered Equity; OptionToAcquire; SecurityToBeAcquired; Date of first sale 2011-12-30; Total offering amount $25,000,000.
- 2010-03-16: Federal exemption Rule 506; 46; Types of securities offered Equity; OptionToAcquire; Date of first sale 2010-03-02; Total offering amount $4,000,000.
| Filed | Federal exemption | Types of securities offered | Date of first sale | Total offering amount | Total amount sold | Total remaining to be sold | Investors who have already invested |
|---|---|---|---|---|---|---|---|
| 2012-03-26 | Rule 506 | Equity; OptionToAcquire; SecurityToBeAcquired | 2011-12-30 | $25,000,000 | $11,091,426 | $13,908,574 | 0 |
| 2012-02-29 D/A | Rule 506 | Equity; OptionToAcquire; SecurityToBeAcquired | 2011-12-30 | $25,000,000 | $25,000,000 | $0 | 416 |
| 2012-02-22 D/A | Rule 506 | Equity; OptionToAcquire; SecurityToBeAcquired | 2011-12-30 | $25,000,000 | $20,875,405 | $4,124,595 | 327 |
| 2010-03-16 | Rule 506; 46 | Equity; OptionToAcquire | 2010-03-02 | $4,000,000 | $2,547,500 | $1,452,500 | 77 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |